1. Administration, F. and D., 2002. Guidance for Industry Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products — Chemistry, Manufacturing, and Controls Documentation 10–15.
2. The assessment of topical nasal drug distribution;Aggarwal;Clin. Otolaryngol. Allied Sci.,2004
3. Baumann, D., 2011. Charakterisierung der Pharmakokinetik und Pharmakodynamik intranasaler Glucocorticoide anhand von in vitro und ex vivo Modellen.
4. Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities and economic burden;Beule;Laryngorhinootologie.,2015
5. Casale, M., Vella, P., Moffa, A., Grimaldi, V., Sabatino, L., Rinaldi, V., Lopez, M.A., Baptista, P., Salvinelli, 2018. The efficacy of topical hyaluronan in rhinosinusitis: a systematic review. J Biol Regul Homeost Agents 31, 71–80.